TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches October 24, 1980
TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again May 27, 1988
